Phibro Animal Health (FRA:PB8) 3-Year EBITDA Growth Rate : 1.40% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health 3-Year EBITDA Growth Rate?

Phibro Animal Health's EBITDA per Share for the three months ended in Mar. 2024 was €0.62.

During the past 12 months, Phibro Animal Health's average EBITDA Per Share Growth Rate was -12.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 1.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -2.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Phibro Animal Health was 17.70% per year. The lowest was -6.60% per year. And the median was 2.25% per year.

Competitive Comparison of Phibro Animal Health's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phibro Animal Health's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's 3-Year EBITDA Growth Rate falls into.

Phibro Animal Health 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Phibro Animal Health (FRA:PB8) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Phibro Animal Health 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Phibro Animal Health (FRA:PB8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

PAHC:USA

Address

300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712

Website

https://www.pahc.com

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Phibro Animal Health (FRA:PB8) Headlines

No Headlines